Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of Indivior PLC INDV rose sharply in today's pre-market trading after the company posted better-than-expected second-quarter results and announced an accelerated $100 million share repurchase program.

Indivior reported quarterly earnings of 44 cents per share which beat the analyst consensus estimate of 14 cents per share. The company reported quarterly sales of $299.00 million which beat the analyst consensus estimate of $296.05 million.

Indivior shares jumped 14.5% to $12.46 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Psyence Biomedical Ltd. PBM rose 157.4% to $1.00 in pre-market trading after the company announced the export of nature-derived psilocybin to Australia and said a trial is projected to be initiated shortly following receipt of drug product by trial sites.
• BloomZ Inc. BLMZ gained 81.2% to $4.44 in pre-market trading after dipping 43% on Wednesday. BloomZ recently priced its IPO at $4.30 per share.
• Tivic Health Systems, Inc. TIVC shares climbed 51.4% to $0.4576 in pre-market trading.
• CERo Therapeutics Holdings, Inc. CERO gained 41.5% to $0.2988 in pre-market trading after gaining around 8% on Wednesday.
• Viking Therapeutics, Inc. VKTX shares gained 20.8% to $60.90 in pre-market trading after the company reported better-than-expected second-quarter EPS results.
• Signing Day Sports, Inc. SGN shares gained 15.9% to $0.2231 in pre-market trading after falling over 12% on Wednesday.
• Stellus Capital Investment Corporation SCM shares surged 15.6% to $16.41 in pre-market trading.
• ELEVAI Labs Inc ELAB gained 15.4% to $0.52 in pre-market trading.
• Day One Biopharmaceuticals, Inc. DAWN shares gained 7.9% to $16.60 in pre-market trading. Ipsen and Day One entered into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor.

Losers

• 2U, Inc. TWOU shares fell 67.7% to $1.33 in pre-market trading. 2U announced a strategic agreement with debtholders to eliminate half of debt and infuse $110 million in new capital.
• IF Bancorp, Inc. IROQ shares declined 59.6% to $6.97 in pre-market trading.
• Edwards Lifesciences Corporation EW shares fell 22% to $67.85 in pre-market trading after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.
• Selina Hospitality PLC SLNA shares fell 19.7% to $0.0367 in pre-market trading after jumping over 75% on Wednesday.
• Ostin Technology Group Co., Ltd. OST shares declined 18.7% to $0.36 in pre-market trading after gaining around 19% on Wednesday.
• MaxLinear, Inc. MXL shares fell 18.1% to $18.25 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
• Regencell Bioscience Holdings Limited RGC fell 16.3% to $11.30 in pre-market trading after declining 10% on Wednesday.
• Hoth Therapeutics, Inc. HOTH fell 15.9% to $0.8998 in pre-market trading. Hoth Therapeutics shares gained around 11% on Wednesday after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer’s disease.
• Bone Biologics Corporation BBLG shares dipped 13% to $1.67 in pre-market trading after jumping 54% on Wednesday.
• Ford Motor Company F shares fell 13% to $11.90 in pre-market trading following a second-quarter earnings miss.

Now Read This:

• Nvidia, McDonald’s And 2 Other Stocks Insiders Are Selling